메뉴 건너뛰기




Volumn 356, Issue 9233, 2000, Pages 881-887

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROTEIN P53; TAMOXIFEN;

EID: 0034626064     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02677-5     Document Type: Article
Times cited : (481)

References (35)
  • 1
    • 0032537396 scopus 로고    scopus 로고
    • Tamoxifen for early breast cancer: An overview of the randomised trials
    • (1998) Lancet , vol.351 , pp. 1451-1467
  • 11
    • 0032537990 scopus 로고    scopus 로고
    • Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
    • (1998) J Natl Cancer Inst , vol.90 , pp. 1371-1388
  • 12
    • 0032508294 scopus 로고    scopus 로고
    • Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
    • (1998) Lancet , vol.352 , pp. 98-101
    • Powles, T.1    Eeles, R.2    Ashley, S.3
  • 13
  • 14
    • 0031667464 scopus 로고    scopus 로고
    • Tamoxifen and endometrial cancer: Most cancers are early stage and highly curable
    • (1998) Eur J Cancer , vol.34 , Issue.SUPPL. 4
    • Barakat, R.1
  • 20
    • 85031601075 scopus 로고
    • Statistical methods in cancer research: the analysis of case-controls studies, vol 1, no 32. Lyon: IARC Scientific Publications
    • (1980)
    • Breslow, N.E.1    Day, N.E.2
  • 29
    • 0031669444 scopus 로고    scopus 로고
    • Alterations in steroid hormone receptors in the tamoxifen-treated endometrium
    • (1998) Eur J Cancer , vol.34 , Issue.SUPPL. 4
    • Schwartz, L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.